Association Between Beta-Blockers And Fracture Risk: A Bayesian Meta-Analysis

Publisher:
Elsevier Science Inc
Publication Type:
Journal Article
Citation:
Bone, 2012, 51 (5), pp. 969 - 974
Issue Date:
2012-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2013005897OK.pdf608.59 kB
Adobe PDF
Background: The association between beta-blockers (BB) and fracture risk is controversial, due largely to conflicting findings from previous studies. The present study sought to evaluate the effect of BB on fracture risk by using a Bayesian meta-analysis approach. Methods and results: We systematically retrieved 13 observational studies on the association between BB use and fracture risk. This meta-analysis involved more than 907.000 men and women with mean/median age of individual studies ranging from 43 to 81 years. We used a hierarchical Bayesian random effects model to synthesize the results. BB use was associated with an average 17% reduction in the risk of any fracture (risk ratio [RR] 0.83: 95% credible interval [Crl]: 0.71-0.93), hip fracture (RR 0.83: 95% Crl: 0.70-0.92) and vertebral fracture (RR 0.81:95% Crl: 0.61-0.99). The probability that BB use reduces fracture risk by at least 10% was 0.91. Conclusions: Beta-blockers are associated with reduced risk of fracture in older adults, but the effect size is likely to be modest. (C) 2012 Elsevier Inc. All rights reserved.
Please use this identifier to cite or link to this item: